Brief: JHBP CY Received Investigational New Drug Approval For Gb492 By NMPA
May 20 (Reuters) - JHBP CY Holdings Ltd 6998.HK :
* RECEIVED INVESTIGATIONAL NEW DRUG APPROVAL FOR GB492 BY
NATIONAL
MEDICAL PRODUCTS ADMINISTRATION
Source text for Eikon: ID:nHKS9w8bbg
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: JHBP CY Says Chairman And CEO Ni Xin To Buy Shares Up To USD 1 Million From Aug 31, 2026
Brief: Edding Genor Group Expects Revenue Of RMB850 MLN-RMB900 MLN For HY
Brief: Jhbp Cy Disposal Of Equity Interest In Candid Therapeutics
Edding Genor climbs on approval of clinical trial of cancer drug in China
Brief: JHBP CY's Phase Ib/Ii Clinical Trial Of Gb268 Obtains IND Approval By NMPA